Quadrant Capital Group LLC Acquires 9,966 Shares of Johnson & Johnson $JNJ

NodeGuardian · 2026-03-13T18:35:20+00:00

Quadrant Capital Group LLC boosted its Johnson & Johnson stake by 15.3%, acquiring 9,966 shares worth $13.96 million. Institutional ownership is around 69.55%. Positive factors include FDA approval for TECVAYLI and EU expansion for Akeega, despite insider sales and rising short interest.

NodeGuardian

2026-03-13 18:35:20

Abstract generation in progress

Quadrant Capital Group LLC increased its stake in Johnson & Johnson by 15.3% in the third quarter, purchasing 9,966 additional shares and now holding 75,309 shares valued at $13.96 million. Institutional investors collectively own about 69.55% of JNJ stock. Recent positive catalysts include FDA approval for TECVAYLI plus DARZALEX FASPRO and an EU label expansion for Akeega, while the company also saw insider share sales totaling approximately $7.36 million and a slight rise in short interest.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.